NEW YORK (April 30, 2016) – Human Microbiology Institute reports the complete genome sequence of novel species Bacillus sp VT-712 isolated from the intestine of a patient with duodenal cancer.

The complete genome sequence has been deposited in the NCBI database under accession no. LWBK00000000. The genome analysis of Bacillus sp VT-712 is ongoing.

“The study for the microbiome of patients with specific types of cancer is crucial for deeper understanding of the microbial role in cancer initiation and progression” said George Tetz, head of R&D department for the Human Microbiology Institute. “We will start with theanalysis of the genome to identify specific genes that  contribute to tumor progression”

The complete genome sequence of Bacillus sp VT-712 and its characterization will allow for a better understanding of its role in patients with duodenal cancer, as well as the host interaction and pathogenicity of this bacterium.